TRADE RECEIVABLES AND OTHER |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||
| Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||
| TRADE RECEIVABLES AND OTHER | NOTE 8 - TRADE RECEIVABLES AND OTHER
Factoring arrangements The Group has entered into several accounts receivable factoring programs with selected financial institutions for certain receivables of the Group. The programs are accounted for as sales of the receivables and had combined limits of approximately $711 million and $729 million at September 30, 2026 and December 31, 2025, respectively. Proceeds on receivables sold under our ongoing factoring programs were $1,103 million and $968 million for the three months ended September 30, 2026 and 2025, respectively. Proceeds on receivables sold under our ongoing factoring programs were $3,092 million and $2,720 million for the nine months ended September 30, 2026 and 2025, respectively. At September 30, 2026 and December 31, 2025, the total amount of receivables derecognized under the Group’s factoring arrangements was $417 million and $430 million, respectively. Starting in fiscal year 2025, the proceeds from the sale of accounts receivables consisted of only cash. Prior to January 1, 2025, the proceeds from the sale of certain of these receivables was comprised of a combination of cash and deferred purchase price receivable. The deferred purchase price receivable was ultimately realized by the Group following the collection by the financial institutions of the underlying receivables sold. For the nine months ended September 30, 2025, the beginning deferred purchase price balance was $2 million, of which $2 million was fully collected in cash. This resulted in an ending deferred purchase price receivable balance of $0 million for the nine months ended September 30, 2025, recorded in Fair value of derivative instruments and other financial assets in the Consolidated Balance Sheets. The Group has recorded 6 million and 5 million of expenses related to its factoring programs in the three months ended September 30, 2026 and 2025, respectively. The Group has recorded $15 million and $16 million of expenses related to its factoring programs in the nine months ended September 30, 2026 and 2025, respectively. These amounts are presented in Other gains and losses – net in its Interim Consolidated Income Statement.
|